Human Papillomavirus (HPV) News and Research

Latest Human Papillomavirus (HPV) News and Research

Inovio third quarter total revenue decreases from $3.6 million to $1.3 million

Inovio third quarter total revenue decreases from $3.6 million to $1.3 million

HPV vaccination rates falter

HPV vaccination rates falter

Women taking HPV vaccine need only two HPV screening tests for rest of their lives: Research

Women taking HPV vaccine need only two HPV screening tests for rest of their lives: Research

Only one-third of young women complete HPV regimen

Only one-third of young women complete HPV regimen

S.A.N.E. Vax calls for federal approval of reliable HPV genotyping test in cervical cancer prevention programs

S.A.N.E. Vax calls for federal approval of reliable HPV genotyping test in cervical cancer prevention programs

HPV vaccine enjoys wide support from medical and public health communities

HPV vaccine enjoys wide support from medical and public health communities

GenMark receives non-exclusive license to Innogenetics' HCV genotyping patent estate

GenMark receives non-exclusive license to Innogenetics' HCV genotyping patent estate

Patients with advanced oropharyngeal cancer caused by HPV have better chances of survival

Patients with advanced oropharyngeal cancer caused by HPV have better chances of survival

Merck reports $342 million net income for 2010 third quarter

Merck reports $342 million net income for 2010 third quarter

CINJ researcher receives Clinical/Basic Science Research Award

CINJ researcher receives Clinical/Basic Science Research Award

Oral cancer linked to oral sex: Study

Oral cancer linked to oral sex: Study

Annual conventional Pap smear is cost effective to reduce cancer incidence and mortality

Annual conventional Pap smear is cost effective to reduce cancer incidence and mortality

National Pap Test Campaign for cervical cancer diagnosis

National Pap Test Campaign for cervical cancer diagnosis

Startech, STRCIC invest $2.5 million in ViroXis Corporation

Startech, STRCIC invest $2.5 million in ViroXis Corporation

New, affordable technology for cervical cancer screening

New, affordable technology for cervical cancer screening

QIAGEN, Abbott enter agreement to strengthen testing menus for automated in-vitro diagnostic applications

QIAGEN, Abbott enter agreement to strengthen testing menus for automated in-vitro diagnostic applications

Smoking leads to epigenetic changes associated with cancer development: Research

Smoking leads to epigenetic changes associated with cancer development: Research

Gen-Probe submits 510(k) application to FDA for APTIMA Trichomonas vaginalis assay on TIGRIS system

Gen-Probe submits 510(k) application to FDA for APTIMA Trichomonas vaginalis assay on TIGRIS system

Dana-Farber doctor hosts live program on Twitter to discuss head and neck cancers

Dana-Farber doctor hosts live program on Twitter to discuss head and neck cancers

Inovio Pharmaceuticals achieves promising results in VGX-3100 Phase I study

Inovio Pharmaceuticals achieves promising results in VGX-3100 Phase I study

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.